Crossmark

Effect of dipeptidyl peptidase IV inhibitors, thiazolidinedione, and sulfonylurea on osteoporosis in patients with type 2 diabetes: population-based cohort study

Crossref DOI link: https://doi.org/10.1007/s00198-020-05801-6

Published Online: 2021-02-16

Published Print: 2021-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yang, B. R.

Cha, S. H.

Lee, K. E.

Kim, J. W.

Lee, J.

Shin, K.-H. https://orcid.org/0000-0002-0915-2700
Funding

Funding for this research was provided by:

Basic Science Research Program through the National Research Foundation of Korea (NRF-2018R1D1A1B07050267)

Bio & Medical Technology Development Program of the National Research Foundation of Korea (NRF-2015M3A9E1028327)
License Information

Text and Data Mining valid from 2021-02-16

Version of Record valid from 2021-02-16
More Information

Article History

Received: 11 June 2020

Accepted: 15 December 2020

First Online: 16 February 2021

Declarations

:

: Bo Ram Yang, SangHun Cha, Kyeong Eun Lee, Jun Woo Kim, Joomi Lee, and Kwang-Hee Shin declare that they have no conflict of interest.

: The study protocol was approved by Kyungpook National University Industry Foundation (No. 2018–0093).

: The requirement for informed consent was waived.

Document is current

Any future updates will be listed below